# Nuro Pharma Inc: Form D filings

Nuro Pharma Inc, a pharmaceuticals company in Las Vegas, NV, filed 3 Form D notices with the SEC between 2012 and 2013. The latest, on June 19, 2013, reports $79,992 sold of a $510,000 offering to 1 investor.

Find out what Nuro Pharma Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Nuro%20Pharma%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Nuro%20Pharma%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fnuro-pharma-inc-1552958)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Nuro%20Pharma%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Nuro%20Pharma%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fnuro-pharma-inc-1552958)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Nevada](https://specstream.ai/data/form-d/state/nevada): 610 rows, by operating companies, filed since November 1, 2024, $30.50, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/nevada
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6380 POLARIS AVE UNIT B, Las Vegas, NV, 89118
- Phone: (702) 269-1941
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506, Securities Act section 4(6)
- SEC identifier (CIK): 1552958

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 19, 2013 | New notice | $510,000 | $79,992 | $430,008 | 1 | Jun 5, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1552958/000155295813000001/0001552958-13-000001-index.htm) |
| Jul 11, 2012 | Amendment | Indefinite | $658,392 | Indefinite | 6 | Jul 2, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1552958/000155295812000002/0001552958-12-000002-index.htm) |
| Jul 10, 2012 | New notice | Indefinite | $658,392 | Indefinite | 6 | Jul 2, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1552958/000155295812000001/0001552958-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Albert Hansen | Director, Promoter |  |
| James Fares | Executive Officer, Director, Promoter |  |

[Every Form D from the week of Jun 17, 2013](https://specstream.ai/data/form-d/week/2013-06-17) · [All recent filings in Nevada](https://specstream.ai/data/form-d/state/nevada) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Nuro Pharma Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).